| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | The CCND1 c.870G>A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma. | Nat Genet | 2013 | 1.31 |
| 2 | Rituximab maintenance improves overall survival of patients with follicular lymphoma-Individual patient data meta-analysis. | Eur J Cancer | 2017 | 0.76 |
| 3 | Lenalidomide overcomes the immunosuppression of regulatory CD8+CD28- T-cells. | Oncotarget | 2017 | 0.75 |